HOME >> BIOLOGY >> NEWS
Findings offer clue to how molecule can both stimulate, suppress cell growth

Scientists are puzzled by the fact that the molecule known as transforming growth factor-beta (TGF-b) generally stops cells from multiplying but at other times promotes cell growth.

Dr. Hal Moses, director of the Vanderbilt-Ingram Cancer Center, and his lab identified TGF-b in 1985 as both a growth stimulator and growth suppressor. Since that time, its role in colon, breast and other cancers has been studied extensively at Vanderbilt and elsewhere.

Now a team of researchers at Vanderbilt-Ingram has found a clue to the seemingly contradictory biological actions of TGF-b. Their findings are published online this week by the Proceedings of the National Academy of Science (www.pnas.org) and is expected to appear in the print version later this month.

"TGF-b usually causes cell growth inhibition; however, many solid tumors over-express TGF-b and the cells aren't inhibited at all in fact, sometimes they grow faster than normal as a result of TGF-b signaling," said Neil A. Bhowmick, Ph.D., assistant professor of Urologic Surgery and senior author on the paper. "Many researchers have studied the ways in which TGF-b suppresses cell growth but not many have examined how it promotes cell growth."

The researchers studied normal cells lines whose growth was inhibited by TGF-b -- the process was working properly as well as cell lines whose growth was stimulated by TGF-b.

TGF-b uses multiple signaling pathways to get its instructions to the cell's nucleus at least four pathways that are known, and there are probably more, Bhowmick said.

In the inhibited cells, the researchers removed particular protein components in one of these known TGF-b signaling pathways called Rho-ROCK. The cells were no longer inhibited and instead began growing again.

Then they did the opposite, adding the protein components to cells whose growth was being stimulated by TGF-b to see if their growth would be arrested again that i
'"/>

Contact: Cynthia Floyd Manley
cynthia.manley@vanderbilt.edu
615-936-5711
Vanderbilt University Medical Center
3-Dec-2003


Page: 1 2

Related biology news :

1. Findings suggest need for new view of p53 cancer proteins interaction with DNA
2. Findings redefine mechanism of action of RNA helicase enzymes
3. Findings of novel nanoproperties in selenium produced by bacteria open new area of exploration
4. Findings could aid efforts to harness nature for making drugs
5. Findings offer further understanding about growth and development in young male gymnasts
6. Findings in frog oocytes may help study of chromosome physiology
7. Findings aid understanding of neurodegenerative diseases
8. Findings show exceptional longevity runs in families
9. Findings give insight into how colon cells transform into precancerous polyps
10. Findings conclude sustained caffeine intake negates the benefits of creatine supplements
11. Findings link disease specific anitbodies to activation of T cells for the first time

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/5/2020)... ... 2020 , ... Greffex, a pioneering vaccine and gene therapy company based in ... the need for a global perspective to make an impact in a post pandemic ... serve as an independent, director of the company. , “The Greffex board is excited ...
(Date:5/30/2020)... Calif. (PRWEB) , ... May 29, 2020 , ... ... enabler of digital transformation for enterprises globally, has collaborated with EchoNous Inc. to ... FDA. It can measure systolic heart function, which has been clinically tested ...
(Date:5/28/2020)... , ... May 27, 2020 , ... ... Workforce Advisor™ , a solution that uniquely combines lab testing insights and ... employers systematically support the ongoing health and safety of employees returning to the ...
Breaking Biology News(10 mins):
(Date:6/28/2020)... ... June 25, 2020 , ... Lumeda Inc. ... cancer, today announced the company has entered a license agreement with Roswell Park ... Lumeda globally exclusive rights to Roswell Park intellectual property surrounding a novel medical ...
(Date:6/23/2020)... ... June 22, 2020 , ... ... antagonist, DRP-104, will be presented June 22-24 during the American Association for Cancer ... and, the other profiles the potent, consistent single agent activity in KEAP1 mutant ...
(Date:6/11/2020)... (PRWEB) , ... June 09, 2020 , ... ... the release of the NEON Micro-Tracer Solution, a highly accurate, contact ... COVID-19 virus in the workplace. Contact tracing, a core disease control measure, is ...
(Date:5/30/2020)... ... May 29, 2020 , ... ... 360°, the first newsletter solely dedicated to the unique role of the Chief ... of perspectives on the responsibilities, problem-solving, best practices and career development of CMOs ...
Breaking Biology Technology:
Cached News: